Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29992201 | 0.86 | XDH (0.42) | XDH | |
| SCHEMBL27167479 | 0.86 | XDH (0.42) | XDH | |
| SCHEMBL30633881 | 0.85 | — | — | |
| SCHEMBL31464229 | 0.85 | — | — | |
| SCHEMBL29082876 | 0.81 | XDH (0.46) | XDH | |
| SCHEMBL30633876 | 0.81 | XDH (0.39) | XDH | |
| SCHEMBL31464227 | 0.81 | XDH (0.39) | XDH | |
| SCHEMBL29082870 | 0.79 | XDH (0.38) | XDH | |
| SCHEMBL26613984 | 0.78 | XDH (0.46) | XDH | |
| SCHEMBL29082877 | 0.76 | TRPV1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289809-A1 | COMPOUNDS USEFUL FOR GOUT | ATOM BIOSCIENCE AMERICA CORPORATION (US) | 2025-09-18 | — | — | US | disclosed |
| EP-4516788-A1 | COMPOUND CAPABLE OF BEING USED FOR GOUT | Atom Therapeutics Co., Ltd (CN) | 2025-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289809-A1 | COMPOUNDS USEFUL FOR GOUT | SLC10A1, ABCG2, SLC10A6 | XDH 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.